Recurrent triple-negative breast cancer
What You Need to Know Triple-negative breast cancer accounts for about 10% to 20%
Full
Breast cancer is clinically categorized into four subtypes on the basis of the
It is now indicated for all TNBC
The average age of onset of breast cancer is about 62 years, thus most patients are in the postmenopause at the first diagnosis of breast cancer
Most ER-positive breast cancers are also PR positive
What Is Triple-Negative Breast Cancer? Triple-negative breast cancer is a kind of breast cancer that does not have any of the receptors that are commonly found in breast cancer
Triple-negative breast cancer symptoms can be more aggressive and is more likely to recur than other breast cancers
Dabrosin C
Methods: Human TNBC MDA-MB-231 cells were divided to the control group (medium treatment), TAM-L group (low concentration TAM treatment, 0
Anticancer drug conjugates may benefit from simultaneous action at two targets potentially overcoming the drawbacks of current cancer treatment, such as insufficient efficacy, high toxicity, and development of resistance
N Engl J Med
Breast cancer is one of at least 13 cancers that are sensitive to obesity and the fat composition of the body
Several studies are currently evaluating the preventive effect of metformin in women at high risk of breast cancer
Introduction: The androgen receptor (AR) is the most highly expressed steroid receptor in breast cancer with 75-95% of estrogen receptor (ER)-positive and 40-70% of ER-negative breast cancers expressing AR
3
Through robust clinical trials and extensive studies, we are making significant strides in understanding breast cancer and Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier